Evidence map›Paper›PMID 39713290›Full record

ArticlebioRxiv : the preprint server for biology2024

Single-nucleus RNA sequencing of human periventricular white matter in vascular dementia.

Sebastián Díaz-Pérez, Jonathan H DeLong, Cyprien A Rivier, Chia-Yi Lee, Michael H Askenase, Biqing Zhu, Le Zhang, Kristen J Brennand, Andrew J Martins, Lauren H Sansing

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sebastián Díaz-PérezDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-3048-9906
Jonathan H DeLongDepartment of Neurology, Yale University School of Medicine, New Haven, CT.
Cyprien A RivierDepartment of Neurology, Yale University School of Medicine, New Haven, CT.
Chia-Yi LeeDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Michael H AskenaseDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT.
Biqing ZhuProgram of Computational Biology and Bioinformatics, Yale University School of Medicine, New Haven, CT.
Le ZhangDepartment of Neurology, Yale University School of Medicine, New Haven, CT.
Kristen J BrennandDepartment of Genetics, Yale University School of Medicine, New Haven, CT.
Andrew J MartinsDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT.
Lauren H SansingDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT.

Funding

INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAMT32AI007019 · NIAID · YALE UNIVERSITY · PI Carrie L. Lucas, David G. Schatz · 1985 to 2026
$14.4M
Modeling the interaction of physiological and environmental stressors on common variants to psychiatric traitsR01ES033630 · NIEHS · YALE UNIVERSITY · PI Kristen Jennifer Brennand · 2022 to 2026
$4.6M
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's DiseaseR01AG068030 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BRENNAND, KRISTEN JENNIFER, CAI, DONGMING · 2020 to 2024
$4.2M
Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's diseaseRF1AG065926 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BRENNAND, KRISTEN JENNIFER, RAJ, TOWFIQUE · 2021 to 2021
$2.4M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
Critical assessment of DNA adenine methylation in brain cells from healthy aging and Alzheimer's diseaseR56AG071291 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BRENNAND, KRISTEN JENNIFER, FANG, GANG · 2021 to 2021
$746k
NIAID NIH HHS T32 AI007019NIA NIH HHS R01 AG068030NIA NIH HHS R56 AG071291NIA NIH HHS RF1 AG065926NIEHS NIH HHS R01 ES033630NIH HHS S10 OD030363
6 · The paper itself

Abstract

Vascular dementia (VaD) refers to a variety of dementias driven by cerebrovascular disease and is the second leading cause of dementia globally. VaD may be caused by ischemic strokes, intracerebral hemorrhage, and/or cerebral small vessel disease, commonly identified as white matter hyperintensities on MRI. The mechanisms underlying these white matter lesions in the periventricular brain are poorly understood. In this study we perform an extensive transcriptomic analysis on human postmortem periventricular white matter lesions in patients with VaD with the goal of identifying molecular pathways in the disease. We find increased cellular stress responses in astrocytes, oligodendrocytes, and oligodendrocyte precursor cells as well as transcriptional and translational repression in microglia in our dataset. We show that several genes identified by GWAS as being associated with white matter disease are differentially expressed in cells in VaD. Finally, we compare our dataset to an independent snRNAseq dataset of PVWM in VaD and a scRNAseq dataset on human iPSC-derived microglia exposed to oxygen glucose deprivation (OGD). We identify the increase of the heat shock protein response as a conserved feature of VaD across celltypes and show that this increase is not linked to OGD exposure. Overall, our study is the first to show that increased heat shock protein responses are a common feature of lesioned PVWM in VaD and may represent a potential therapeutic target.

Identifiers

PMID39713290
PMCPMC11661092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.